Skip to main content
Skip to footer

Michale Murphy

Michale Murphy, Executive Director, Head of Pharmacovigilance Operation, Amgen

Michael D. Murphy leads the PV Operations team within Global Patient Safety at Amgen, a position he has held since April 2019.  Responsibilities include overseeing and managing teams accountable for adverse event case processing and medical review, periodic reporting, safety reporting obligations for clinical, commercial/marketing programs, and oversight of the safety technologies.  Michael has over 20 years of experience within the pharmaceutical industry, focused within Pharmacovigilance, with expertise in Change Management, Process Excellence, and Safety Systems